PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition.

Komatsu, K; Wharton, W; Hang, H; Wu, C; Singh, S; Lieberman, H B; Pledger, W J; Wang, H G

Komatsu, K; Wharton, W; Hang, H; Wu, C; Singh, S; Lieberman, H B; Pledger, W J; Wang, H G.

Affiliation

Komatsu K; Drug Discovery Program, H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, Florida, FL 33612, USA.

Oncogene ; 19(46): 5291-7, 2000 Nov 02.

Article in En | MEDLINE | ID: mdl-11077446

Subject(s)

Cell Cycle Proteins/metabolism; DNA Damage; DNA Replication; Proliferating Cell Nuclear Antigen/metabolism; Active Transport, Cell Nucleus/drug effects; Active Transport, Cell Nucleus/radiation effects; Cell Cycle/drug effects; Cell Cycle/radiation effects; Cell Division/drug effects; Cell Division/radiation effects; Cell Line; Cell Nucleus/drug effects; Cell Nucleus/metabolism; Cell Nucleus/radiation effects; Cells, Cultured; Cytoplasm/drug effects; Cytoplasm/metabolism; Cytoplasm/radiation effects; DNA Damage/radiation effects; DNA Replication/drug effects; Fibroblasts; Gamma Rays; Humans; Hydroxyurea/pharmacology; Macromolecular Substances; Protein Binding/drug effects; Protein Binding/radiation effects; Schizosaccharomyces pombe Proteins; Skin; Two-Hybrid System Techniques

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: DNA Damage / Proliferating Cell Nuclear Antigen / Cell Cycle Proteins / DNA Replication Limits: Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2000 Document type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links